BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29246939)

  • 21. Molecular and immune targets for Merkel cell carcinoma therapy and prevention.
    Cohen L; Tsai KY
    Mol Carcinog; 2019 Sep; 58(9):1602-1611. PubMed ID: 31116890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shared Oncogenic Pathways Implicated in Both Virus-Positive and UV-Induced Merkel Cell Carcinomas.
    González-Vela MDC; Curiel-Olmo S; Derdak S; Beltran S; Santibañez M; Martínez N; Castillo-Trujillo A; Gut M; Sánchez-Pacheco R; Almaraz C; Cereceda L; Llombart B; Agraz-Doblas A; Revert-Arce J; López Guerrero JA; Mollejo M; Marrón PI; Ortiz-Romero P; Fernandez-Cuesta L; Varela I; Gut I; Cerroni L; Piris MÁ; Vaqué JP
    J Invest Dermatol; 2017 Jan; 137(1):197-206. PubMed ID: 27592799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8
    Jing L; Ott M; Church CD; Kulikauskas RM; Ibrani D; Iyer JG; Afanasiev OK; Colunga A; Cook MM; Xie H; Greninger AL; Paulson KG; Chapuis AG; Bhatia S; Nghiem P; Koelle DM
    Cancer Immunol Res; 2020 May; 8(5):648-659. PubMed ID: 32179557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma.
    Starrett GJ; Thakuria M; Chen T; Marcelus C; Cheng J; Nomburg J; Thorner AR; Slevin MK; Powers W; Burns RT; Perry C; Piris A; Kuo FC; Rabinowits G; Giobbie-Hurder A; MacConaill LE; DeCaprio JA
    Genome Med; 2020 Mar; 12(1):30. PubMed ID: 32188490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of distant metastases in 215 Merkel cell carcinoma patients: Implications for prognosis and surveillance.
    Lewis CW; Qazi J; Hippe DS; Lachance K; Thomas H; Cook MM; Juhlin I; Singh N; Thuesmunn Z; Takagishi SR; McEvoy A; Doolittle-Amieva C; Bhatia S; Paulson KG; O'Malley RB; Wang CL; Nghiem P
    Cancer Med; 2020 Feb; 9(4):1374-1382. PubMed ID: 31883234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of expression of the hedgehog signal with Merkel cell polyomavirus infection and prognosis of Merkel cell carcinoma.
    Kuromi T; Matsushita M; Iwasaki T; Nonaka D; Kuwamoto S; Nagata K; Kato M; Akizuki G; Kitamura Y; Hayashi K
    Hum Pathol; 2017 Nov; 69():8-14. PubMed ID: 28551328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I.
    Chapuis AG; Afanasiev OK; Iyer JG; Paulson KG; Parvathaneni U; Hwang JH; Lai I; Roberts IM; Sloan HL; Bhatia S; Shibuya KC; Gooley T; Desmarais C; Koelle DM; Yee C; Nghiem P
    Cancer Immunol Res; 2014 Jan; 2(1):27-36. PubMed ID: 24432305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors.
    Lyngaa R; Pedersen NW; Schrama D; Thrue CA; Ibrani D; Met O; Thor Straten P; Nghiem P; Becker JC; Hadrup SR
    Clin Cancer Res; 2014 Apr; 20(7):1768-78. PubMed ID: 24526738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant expression of ALK and EZH2 in Merkel cell carcinoma.
    Veija T; Koljonen V; Bohling T; Kero M; Knuutila S; Sarhadi VK
    BMC Cancer; 2017 Mar; 17(1):236. PubMed ID: 28359267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunotherapy for Merkel cell carcinoma.
    Angeles CV; Sabel MS
    J Surg Oncol; 2021 Mar; 123(3):775-781. PubMed ID: 33595894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting Merkel Cell Carcinoma by Engineered T Cells Specific to T-Antigens of Merkel Cell Polyomavirus.
    Gavvovidis I; Leisegang M; Willimsky G; Miller N; Nghiem P; Blankenstein T
    Clin Cancer Res; 2018 Aug; 24(15):3644-3655. PubMed ID: 29669806
    [No Abstract]   [Full Text] [Related]  

  • 32. Merkel Cell Carcinoma Therapeutic Update.
    Cassler NM; Merrill D; Bichakjian CK; Brownell I
    Curr Treat Options Oncol; 2016 Jul; 17(7):36. PubMed ID: 27262710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LRIG1 is a positive prognostic marker in Merkel cell carcinoma and Merkel cell carcinoma expresses epithelial stem cell markers.
    Sundqvist B; Sihto H; von Willebrand M; Böhling T; Koljonen V
    Virchows Arch; 2021 Dec; 479(6):1197-1207. PubMed ID: 34331569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An analysis of the use of targeted therapies in patients with advanced Merkel cell carcinoma and an evaluation of genomic correlates of response.
    Knepper TC; Panchaud RA; Muradova E; Cohen L; DeCaprio JA; Khushalani NI; Tsai KY; Brohl AS
    Cancer Med; 2021 Sep; 10(17):5889-5896. PubMed ID: 34269527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular E-selectin expression correlates with CD8 lymphocyte infiltration and improved outcome in Merkel cell carcinoma.
    Afanasiev OK; Nagase K; Simonson W; Vandeven N; Blom A; Koelle DM; Clark R; Nghiem P
    J Invest Dermatol; 2013 Aug; 133(8):2065-73. PubMed ID: 23353989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Updates on Merkel Cell Carcinoma.
    Emge DA; Cardones AR
    Dermatol Clin; 2019 Oct; 37(4):489-503. PubMed ID: 31466589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival.
    Paulson KG; Iyer JG; Tegeder AR; Thibodeau R; Schelter J; Koba S; Schrama D; Simonson WT; Lemos BD; Byrd DR; Koelle DM; Galloway DA; Leonard JH; Madeleine MM; Argenyi ZB; Disis ML; Becker JC; Cleary MA; Nghiem P
    J Clin Oncol; 2011 Apr; 29(12):1539-46. PubMed ID: 21422430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6-7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A.
    Guadagni S; Farina AR; Cappabianca LA; Sebastiano M; Maccarone R; Zelli V; Clementi M; Chiominto A; Bruera G; Ricevuto E; Fiorentini G; Sarti D; Mackay AR
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell Carcinomas.
    Wong SQ; Waldeck K; Vergara IA; Schröder J; Madore J; Wilmott JS; Colebatch AJ; De Paoli-Iseppi R; Li J; Lupat R; Semple T; Arnau GM; Fellowes A; Leonard JH; Hruby G; Mann GJ; Thompson JF; Cullinane C; Johnston M; Shackleton M; Sandhu S; Bowtell DD; Johnstone RW; Fox SB; McArthur GA; Papenfuss AT; Scolyer RA; Gill AJ; Hicks RJ; Tothill RW
    Cancer Res; 2015 Dec; 75(24):5228-34. PubMed ID: 26627015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of PI3K signaling in Merkel cell carcinoma.
    Nardi V; Song Y; Santamaria-Barria JA; Cosper AK; Lam Q; Faber AC; Boland GM; Yeap BY; Bergethon K; Scialabba VL; Tsao H; Settleman J; Ryan DP; Borger DR; Bhan AK; Hoang MP; Iafrate AJ; Cusack JC; Engelman JA; Dias-Santagata D
    Clin Cancer Res; 2012 Mar; 18(5):1227-36. PubMed ID: 22261808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.